All Is Well: Heal Your Body With Medicine, Affirmations, and Intuition (41 page)

Psychosomatic Medicine
51, no. 2 (March–April 1989): 113–122; G. Weidner

et al., “The Role of Type A Behavior and Hostility in an Elevation of Plasma

Lipids in Adult Women and Men,”
Psychosomatic Medicine
49, no. 2 (March–

April 1987): 136–145.

8. L.H. Powell et al., “Can the Type A Behavior Pattern Be Altered after

Myocardial Infarction? A Second-Year Report for the Recurrent Coronary

Prevention Project,”
Psychosomatic Medicine
46, no. 4 (July–August 1984):

293–313.

9. D. Giugliano et al., “The Effects of Diet on Inflammation: Emphasis on the

Metabolic Syndrome,”
Journal of the American College of Cardiology
48, no.

4 (August 15, 2006): 677–685; C.M. Licht et al., “Depression Is Associated

With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for

Hypertension,”
Hypertension
53, no. 4 (April 2009): 631–638; G. Seematter

et al., “Stress and Metabolism,”
Metabolic Syndrome and Related Disorders

3, no. 1 (2005): 8–13; I. Pilowsky et al., “Hypertension and Personality,”

Psychosomatic Medicine
35, no. 1 (January–February 1973): 50–56; J.P. Henry

and J.C. Cassel, “Psychosocial Factors in Essential Hypertension. Recent

Epidemiologic and Animal Experimental Evidence,”
American Journal of

Epidemiology
90, no. 3 (September 1969): 171–200.

10. P.J. Clayton, “Mortality and Morbidity in the First Year of Widowhood,”

Archives of General Psychiatry
30, no. 6 (June 1974): 747–750; C.M. Parkes and

R.J. Brown, “Health After Bereavement: A Controlled Study of Young Boston

Widows and Widowers,”
Psychosomatic Medicine
34, no. 5 (September–

October 1972): 449–461; M. Young et al., “The Mortality of Widowers,”
The

Lancet
282, no. 7305 (August 1963): 454–457.

11. W.T. Talman, “Cardiovascular Regulation and Lesions of the Central Nervous

System,”
Annals of Neurology
18, no. 1 (July 1985): 1–13; P.D. Wall and

G.D. Davis, “Three Cerebral Cortical Systems Affecting Autonomic

Function,”
Journal of Neurophysiology
14, no. 6 (November 1951): 507–517;

G.R. Elliot and C. Eisdorfer,
Stress and Human Health: Analysis and Implications

of Research
(New York: Springer, 1982).

231

All Is Well interior.indd 231

1/8/13 7:51 AM

A ll i s w e ll

12. R.J. Tynan et al., “A Comparative Examination of the Anti-inflammatory

Effects of SSRI and SNRI Antidepressants on LPS Stimulated Microglia,”
Brain,

Behavior, and Immunity
26, no. 3 (March 2012): 469–479; L. Mehl-Madrona,

“Augmentation of Conventional Medical Management of Moderately Severe

or Severe Asthma with Acupuncture and Guided Imagery/Meditation,”
The

Permanente Journal
12, no. 4 (Fall 2008): 9–14.

13. A.C. Ropoteanu, “The Level of Emotional Intelligence for Patients with

Bronchial Asthma and a Group Psychotherapy Plan in 7 Steps,”
Romanian

Journal of Internal Medicine
49, no. 1 (2011): 85–91.

14. C. Jasmin et al., “Evidence for a Link Between Certain Psychological Factors

and the Risk of Breast Cancer in a Case-Control Study. Psycho-Oncologic

Group (P.O.G.),”
Annals of Oncology
1, no. 1 (1990): 22–29; M. Tarlau and

I. Smalheiser, “Personality Patterns in Patients with Malignant Tumors of the

Breast and Cervix,”
Psychosomatic Medicine
13, no. 2 (March 1951): 117–121;

L. LeShan, “Psychological States as Factors in the Development of Malignant

Disease: A Critical Review,”
Journal of the National Cancer Institute
22, no. 1

(January 1959): 1–18; H. Becker, “Psychodynamic Aspects of Breast Cancer.

Differences in Younger and Older Patients,”
Psychotherapy and Psychosomatics

32, nos. 1–4 (1979): 287–296; H. Snow,
The Proclivity of Women to Cancerous

Diseases and to Certain Benign Tumors
(London: J. & A. Churchill, 1891);

H. Snow,
Clinical Notes on Cancer
(London: J. & A. Churchill, 1883).

15. D. Razavi et al., “Psychosocial Correlates of Oestrogen and Progesterone

Receptors in Breast Cancer,”
The Lancet
335, no. 3695 (April 21, 1990):

931–933; S.M. Levy et al., “Perceived Social Support and Tumor Estrogen/

Progesterone Receptor Status as Predictors of Natural Killer Cell Activity in

Breast Cancer Patients,”
Psychosomatic Medicine
52, no. 1 (January–February

1990): 73–85; S. Levy et al., “Correlation of Stress Factors with Sustained

Depression of Natural Killer Cell Activity and Predicted Prognosis in Patients

with Breast Cancer,”
Journal of Clinical Oncology
5, no. 3 (March 1987): 348–

353; A. Brémond et al., “Psychosomatic Factors in Breast Cancer Patients:

Results of a Case Control Study,”
Journal of Psychosomatic Obstetrics &

Gynecology
5, no. 2 (January 1986): 127–136; K.W. Pettingale et al., “Mental

Attitudes to Cancer: An Additional Prognostic Factor,”
The Lancet
1, no.

8431 (March 1985): 750; M. Wirsching et al., “Psychological Identification

of Breast Cancer Patients before Biopsy,”
Journal of Psychosomatic Research

26, no. 1 (1982): l–10; K.W. Pettingale et al., “Serum IgA and Emotional

Expression in Breast Cancer Patients,”
Journal of Psychosomatic Research
21,

no. 5 (1977): 395–399.

16. M. Eskelinen and P. Ollonen, ”Assessment of ‘Cancer-prone Personality’

Characteristics in Healthy Study Subjects and in Patients with Breast Disease

and Breast Cancer Using the Commitment Questionnaire: A Prospective

Case–Control Study in Finland,”
Anticancer Research
31, no. 11 (November

2011): 4013–4017.

17. J. Giese-Davis et al., “Emotional Expression and Diurnal Cortisol Slope

in Women with Metastatic Breast Cancer in Supportive-Expressive Group

Therapy: A Preliminary Study,”
Biological Psychology
73, no. 2 (August 2006):

190–198; D. Spiegel et al., “Effect of Psychosocial Treatment on Survival of

232

All Is Well interior.indd 232

1/8/13 7:51 AM

Endnotes

Patients with Metastatic Breast Cancer,”
The Lancet
2, no. 8668 (October 14,

1989): 888–891; S.M. Levy et al., “Prognostic Risk Assessment in Primary

Breast Cancer by Behavioral and Immunological Parameters,”
Health

Psychology
4, no. 2 (1985): 99–113; S. Greer et al., “Psychological Response

to Breast Cancer: Effect of Outcome,”
The Lancet
314, no. 8146 (October 13,

1979): 785–787.

Fifth Emotional Center

1. A.W. Bennett and C.G. Cambor, “Clinical Study of Hyperthyroidism:

Comparison of Male and Female Characteristics,”
Archives of General

Psychiatry
4, no. 2 (February 1961): 160–165.

2. American Association of University Women,
Shortchanging Girls,

Shortchanging America
(Washington, D.C.: American Association of University

Women, 1991); G. Johansson et al., “Examination Stress Affects Plasma

Levels of TSH and Thyroid Hormones Differently in Females and Males,”

Psychosomatic Medicine
49, no. 4 (July–August 1987): 390–396; J.A. Sherman,

Sex-Related Cognitive Differences: An Essay on Theory and Evidence,
(Springfield, Ill.: Charles C. Thomas, 1978).

3. K. Yoshiuchi et al., “Stressful Life Events and Smoking Were Associated With

Graves’ Disease in Women, but Not in Men,”
Psychosomatic Medicine
60,

no. 2 (March–April 1998): 182–185; J.L. Griffith and M.E. Griffith,
The Body

Speaks: Therapeutic Dialogues for Mind-Body Problems
(New York: Basic Books,

1994); D. Kimura, “Sex Differences in Cerebral Organization for Speech and

Praxic Functions,”
Canadian Journal of Psychology
37, no. 1 (March 1983):

19–35.

4. G. Johansson et al., “Examination Stress Affects Plasma Levels of TSH and

Thyroid Hormones Differently in Females and Males,”
Psychosomatic Medicine

49, no. 4 (July–August 1987): 390–396.

5. S.K. Gupta et al., “Thyroid Gland Responses to Intermale Aggression in an

Inherently Aggressive Wild Rat,”
Endokrinologie
80, no. 3 (November 1982):

350–352.

6. American Association of University Women,
Shortchanging Girls,

Shortchanging America
(Washington, D.C.: American Association of University

Women, 1991).

7. American Association of University Women,
Shortchanging Girls,

Shortchanging America
(Washington, D.C.: American Association of University

Women, 1991).

8. H. Glaesmer et al., “The Association of Traumatic Experiences and

Posttraumatic Stress Disorder with Physical Morbidity in Old Age: A German

Population-Based Study,”
Psychosomatic Medicine
73, no. 5 (June 2011):

401–406; T. Mizokami et al., ”Stress and Thyroid Autoimmunity,”
Thyroid

14, no. 12 (December 2004): 1047–1055; V.R. Radosavljević et al., “Stressful

233

All Is Well interior.indd 233

1/8/13 7:51 AM

A ll i s w e ll

Life Events in the Pathogenesis of Graves’ Disease,”
European Journal of

Endocrinology
134, no. 6 (June 1996): 699–701; N. Sonino et al., “Life

Events in the Pathogenesis of Graves’ Disease: A Controlled Study,”
Acta

Endocrinologica
128, no. 4 (April 1993): 293–296; T. Harris et al., “Stressful

Life Events and Graves’ Disease,”
The British Journal of Psychiatry
161

(October 1992): 535–541; B. Winsa et al., “Stressful Life Events and Graves’

Disease,”
The Lancet
338, no. 8781 (December 14, 1991): 1475–1479;

S.A. Weisman, “Incidence of Thyrotoxicosis among Refugees from Nazi

Prison Camps,”
Annals of Internal Medicine
48, no. 4 (April 1958): 747–752.

9. I.J. Cook et al., “Upper Esophageal Sphincter Tone and Reactivity to Stress in

Patients with a History of Globus Sensation,”
Digestive Diseases and Sciences

34, no. 5 (May 1989): 672–676; J.P. Glaser and G.L. Engel, “Psychodynamics,

Psychophysiology and Gastrointestinal Symptomatology,”
Clinics in

Gastroenterology
6, no. 3 (September 1977): 507–531.

10. B. Rai et al., “Salivary Stress Markers, Stress, and Periodontitis: A Pilot Study,”

Journal of Periodontology
82, no. 2 (February 2011): 287–292; A.T. Merchant

et al., ”A Prospective Study of Social Support, Anger Expression and Risk

of Periodontitis in Men”
Journal of the American Dental Association
134, no.

12 (December 2003): 1591–1596; R.J. Genco et al., ”Relationship of Stress,

Distress and Inadequate Coping Behaviors to Periodontal Disease,”
Journal of

Periodontology
70, no. 7 (July 1999): 711–723.

Sixth Emotional Center

1. I. Pilowsky et al., “Hypertension and Personality,”
Psychosomatic Medicine

35, no. 1 (January–February 1973): 50–56; H.O. Barber, “Psychosomatic

Disorders of Ear, Nose and Throat,”
Postgraduate Medicine
47, no. 5 (May

1970): 156–159.

2. K. Czubulski et al., “Psychological Stress and Personality in Ménière’s

Disease,”
Journal of Psychosomatic Research
20, no. 3 (1976): 187–191.

3. A. Brook and P. Fenton, “Psychological Aspects of Disorders of the Eye:

A Pilot Research Project,”
The Psychiatrist
18 (1994): 135–137; J. Wiener,

“Looking Out and Looking In: Some Reflections on ‘Body Talk’ in the

Consulting Room,”
The Journal of Analytic Psychology
39, no. 3 (July 1994):

331–350; L. Yardley, “Prediction of Handicap and Emotional Distress in

Patients with Recurrent Vertigo Symptoms, Coping Strategies, Control Beliefs

and Reciprocal Causation,”
Social Science and Medicine
39, no. 4 (1994): 573–

581; C. Martin et al., “Ménière’s Disease: A Psychosomatic Disease?”
Revue

de Laryngologie, Otologie, Rhinologie
112, no. 2 (1991): 109–111; C. Martin

et al., “Psychologic Factor in Ménière’s Disease,”
Annales d’Oto-laryngologie

et de Chirurgie Cervico Faciale
107, no. 8 (1990): 526–531; M. Rigatelli et

al., “Psychosomatic Study of 60 Patients with Vertigo,”
Psychotherapy and

Psychosomatics
41, no. 2 (1984): 91–99; F.E. Lucente, “Psychiatric Problems

in Otolaryngology,”
Annals of Otology, Rhinology, and Laryngology
82, no. 3

(May–June 1973): 340–346.

234

All Is Well interior.indd 234

1/8/13 7:51 AM

Endnotes

4. V. Raso et al., “Immunological Parameters in Elderly Women: Correlations

with Aerobic Power, Muscle Strength and Mood State,”
Brain, Behavior, and

Immunity
26, no. 4 (May 2012): 597–606; O.M. Wolkowitz et al., “Of Sound

Mind and Body: Depression, Disease, and Accelerated Aging,”
Dialogues in

Clinical Neuroscience
13, no. 1 (2011): 25–39; M.F. Damholdt et al., “The

Parkinsonian Personality and Concomitant Depression,”
The Journal of

Neuropsychiatry and Clinical Neurosciences
23, no. 1 (Fall 2011): 48–55;